InfuSystem Holdings, Inc.
$10.79
▼
-0.11%
2026-04-21 07:31:01
www.infusystem.com
ASE: INFU
Explore InfuSystem Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$213.43 M
Current Price
$10.79
52W High / Low
$11.04 / $4.66
Stock P/E
32.21
Book Value
$2.84
Dividend Yield
—
ROCE
14.83%
ROE
11.54%
Face Value
—
EPS
$0.31
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
461
Beta
1.55
Debt / Equity
42.63
Current Ratio
1.8
Quick Ratio
1.53
Forward P/E
32.34
Price / Sales
1.33
Enterprise Value
$210.87 M
EV / EBITDA
8.74
EV / Revenue
1.47
Rating
Strong Buy
Target Price
$14.9
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Tivic Health Systems, Inc. | $1.13 | — | $3.25 M | — | -25.51% | -82.69% | $13.23 / $0.72 | $6.65 |
| 2. | CVRx, Inc. | $7.24 | — | $193.65 M | — | -56.04% | -96.59% | $11.3 / $4.3 | $1.5 |
| 3. | Insulet Corporation | $193.4 | 55.6 | $13.48 B | — | 18.87% | 18.12% | $354.88 / $194.61 | $21.53 |
| 4. | AdaptHealth Corp. | $12.67 | — | $1.72 B | — | 5.17% | -4.25% | $12.87 / $7.11 | $11.46 |
| 5. | NeuroOne Medical Technologies Corporation | $4.98 | — | $40.89 M | — | -49.83% | -1.46% | $6.96 / $3 | $0.13 |
| 6. | Envoy Medical, Inc. | $0.7 | — | $54.48 M | 3.34% | 741.34% | 155.22% | $1.91 / $0.36 | $-0.41 |
| 7. | Sensus Healthcare, Inc. | $4.06 | — | $66.84 M | — | -21.33% | -14.85% | $5.92 / $3.03 | $1.57 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 36.23 M | 36.49 M | 36 M | 34.72 M | 33.85 M |
| Operating Profit | 3.71 M | 3.81 M | 3.78 M | 0.62 M | 2.62 M |
| Net Profit | 2.04 M | 2.26 M | 2.6 M | -0.27 M | 0.93 M |
| EPS in Rs | 0.1 | 0.11 | 0.13 | -0.01 | 0.05 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 143.44 M | 134.86 M | 125.78 M | 109.91 M |
| Operating Profit | 11.92 M | 6.89 M | 4.09 M | 1.65 M |
| Net Profit | 6.63 M | 2.35 M | 0.87 M | 0.02 M |
| EPS in Rs | 0.33 | 0.12 | 0.04 | 0 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 100.56 M | 103.61 M | 102.92 M | 99.39 M |
| Total Liabilities | 43.23 M | 46.09 M | 50.61 M | 51.38 M |
| Equity | 57.33 M | 57.53 M | 52.3 M | 48 M |
| Current Assets | 36.34 M | 32.16 M | 30.62 M | 24.78 M |
| Current Liabilities | 20.18 M | 17.66 M | 15.71 M | 14.47 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 24.41 M | 20.46 M | 11.22 M | 17.52 M |
| Investing CF | -6.79 M | -13.24 M | -6.73 M | -11.48 M |
| Financing CF | -14.96 M | -6.92 M | -4.42 M | -6.06 M |
| Free CF | 15.72 M | 2.63 M | 0.11 M | 2.44 M |
| Capex | -8.69 M | -17.83 M | -11.12 M | -15.08 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 7.22% | 14.44% | — | — |
| Earnings Growth % | 168.92% | 4744.44% | — | — |
| Profit Margin % | 1.74% | 0.69% | 0.02% | — |
| Operating Margin % | 5.11% | 3.25% | 1.5% | — |
| Gross Margin % | 52.2% | 50.17% | 55.1% | — |
| EBITDA Margin % | 14.34% | 13.14% | 13.55% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.